Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...

The Molecular Diagnostics - Infectious Disease sector offers growth opportunities with biotech advancements, particularly in genomics. Key trends include nucleic acid testing and immunoassay ...

Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...

Gastric Cancer Diagnostics Market size was valued at US$ 3.5 Bn in 2024 and is projected to reach US$ 6.9 Bn by 2035, growing ...

A groundbreaking study introduces new noninvasive screening tools that have the potential to greatly enhance patient comfort ...

Cell free RNA diagnostics market is projected to reach US$ 204.5 Mn by 2035, expanding at a CAGR of 14.5% from 2025 to 2035 ...

A stronger domestic industry will not just boost the local industry and reduce the import bill but also ensure that ...

Shard Diagnostic has become the latest company to join the University of Nottingham's investment portfolio, supported through ...

SALT LAKE CITY, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced it will present new data in eight ...

Diagnostics, Inc. held a special meeting of shareholders where a proposal to amend the company’s Articles of Incorporation was approved. This amendment allows for a reverse stock split of the ...

Discover how Dr. Manjiri Bakre's OncoStem Diagnostics is transforming early-stage breast cancer treatment with CanAssist-Breast, an AI-powered prognostic test that offers personalized risk predictions ...

The assay detects aggressive prostate tumors in men on active surveillance for low-risk cancer, potentially helping them ...